Individualized Dosimetry for Holmium-166 Radioembolization in Patients With Unresectable Hepatocellular Carcinoma
Clinical trial NCT06302400 · TERMINATED
Trial details
- NCT number
- NCT06302400
- Sponsor
- Imperial College London
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-22
- Primary completion
- 2025-03-04
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.